Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Individual results vary and no outcome can be guaranteed
Who May Benefit Most People with dysbiosis, an imbalance of gut bacteria often seen in those with obesity or type 2 diabetes, may see the most notable results
The company is studying the drug in a Phase 1 clinical study titled "A Randomized, Double-Blind, Placebo and Comparator-Controlled Crossover Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes"
TNF receptor superfamily-induced cell death: Redox-dependent execution
Manufacturing and Distribution Costs GLP1 medications are biologics, which means they are derived from living organisms and require complex manufacturing processes
have shown that inhibition of PSC activation is associated with a decrease in islet fibrosis and an increase in insulin secretion [35], indicating the potential role of PSC activation in -cell failure
US$ 28.02
US$ 25.50
US$ 24.36
US$ 20.20
US$ 23.19
US$ 20.22
US$ 24.49
US$ 23.23
US$ 26.80
